Warning letter
Community Blood Center of Greater Kansas City: warning letter of Mar 9, 2006
FDA warning letter UCM075819 · Kansas City District Office
Key facts
| Reference number | UCM075819 |
|---|---|
| Company | Community Blood Center of Greater Kansas City |
| Subject | Current Good Manufacturing Practices Regulations for Blood & Blood Components/Adulterated |
| Issue date | Mar 9, 2006 |
| Posted date | Mar 9, 2006 |
| Issuing office | Kansas City District Office |
| Product type | Unknown |
| CFR sections cited | 606, 606.20, 606.100(c), 606.170(a), 606.100(b), 606.100(b)(20), 610.40(b) |
| Country | 3 |
| Inspection city | Kansas City |
| Inspection ZIP | 64111-2308 |
| Inspection start date | Nov 18, 2005 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: